140
Wang CY, Mayo MW, Baldwin AS Jr (1996) TNF- and cancer therapy-induced apoptosis: poten-
tiation by inhibition of NF-kappaB. Science 274(5288):784–787
Wang J, Wakeman TP, Latha JD et al (2010a) Notch promotes radioresistance of glioma stem cells.
Stem Cells 28(1):17–28
Wang R, Chadalavada K, Wilshire J et al (2010b) Glioblastoma stem-like cells give rise to tumour
endothelium. Nature 468(7325):829–833
Weller M, Cloughesy T, Perry JR, Wick W (2012) Standards of care for treatment of recurrent
glioblastoma—are we there yet? Neurooncology 2012
Wolburg H, Lippoldt A (2002) Tight junctions of the blood–brain barrier: development, composi-
tion and regulation. Vasc Pharmacol 38(6):323–337
Yao X, Ping Y, Liu Y et al (2013) Vascular endothelial growth factor receptor 2 (VEGFR-2) plays
a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by
Glioma stem-like cells. PLoS One 8(3):e57188
Yong RL, Lonser RR (2011) Surgery for glioblastoma multiforme: striking a balance. World
Neurosurg 76(6):528–530
Zhong H, De Marzo AM, Laughner E et al (1999) Overexpression of hypoxia-inducible factor
1alpha in common human cancers and their metastases. Cancer Res 59(22):5830–5835
Zhu Z, Hao X, Yan M et al (2010) Cancer stem/progenitor cells are highly enriched in
CD133+CD44+ population in hepatocellular carcinoma. Int J Cancer 126(9):2067–2078
A. Sattiraju et al.